Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2005-11-08
2005-11-08
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001370, C424S001650, C424S009100
Reexamination Certificate
active
06962687
ABSTRACT:
A method of detecting inflammatory processes comprises (a) administering per-orally or per-rectally a composition comprising a diagnostically effective amount of L-[guanido-15N2]-arginine, L-[guanido-15N]-arginine, their mixtures and pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier; (b) collecting a sample of exhaled air, saliva or urine; (c) determining13NO in the air sample or its transformation products15IN-nitrite and/or15N-nitrate in the saliva sample or urine. Also disclosed is a corresponding diagnostic composition for use in diagnosing inflammatory processes and a method for its manufacture.
REFERENCES:
patent: 6379649 (2002-04-01), Katsifis et al.
patent: 19719098 (1999-05-01), None
patent: WO 96/17244 (1996-06-01), None
patent: WO 97/37587 (1997-10-01), None
Forte et al, Hypertension (1998), 32(4) 730-734.
Forte et al., “Measurement of Nitric Oxide Synthesis in Humans Using L-[15N2]Arginine”, Methods in Enzymology, vol. 301, pp. 92-98 (1999).
Lundqvist Thomas
Pettersson Anders
Dickstein Shapiro Morin & Oshinsky LLP.
Jones Dameron L.
Orexo AB
LandOfFree
Method and means for detecting inflammatory processes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and means for detecting inflammatory processes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and means for detecting inflammatory processes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3487959